HCV Patent Case: With "Unclean Hands," Merck Can't Collect Jury Award From Gilead

Gilead scored a victory in its patent dispute with Merck, in which the latter company was accused by a federal judge of egregious misconduct and being guilty of "unclean hands," and therefore, could not collect the $200m jury award the company had earlier won.